$CLFD
Clearfield, Inc.

2023 Q3 Form 10-Q Financial Statement

#000117184323005112 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $49.69M $61.28M
YoY Change -47.72% -13.99%
Cost Of Revenue $37.69M $42.21M
YoY Change -34.48% 0.64%
Gross Profit $11.99M $19.07M
YoY Change -68.02% -34.92%
Gross Profit Margin 24.14% 31.12%
Selling, General & Admin $10.28M $13.45M
YoY Change -32.62% 5.72%
% of Gross Profit 85.69% 70.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.644M $1.579M
YoY Change 32.69% 94.46%
% of Gross Profit 13.71% 8.28%
Operating Expenses $10.28M $13.45M
YoY Change -32.62% 5.72%
Operating Profit $1.716M $5.625M
YoY Change -92.29% -66.09%
Interest Expense $1.548M $195.0K
YoY Change -679.78% 353.49%
% of Operating Profit 90.21% 3.47%
Other Income/Expense, Net
YoY Change
Pretax Income $3.264M $7.060M
YoY Change -85.15% -57.54%
Income Tax $568.0K $1.842M
% Of Pretax Income 17.4% 26.09%
Net Earnings $2.696M $5.218M
YoY Change -84.13% -59.06%
Net Earnings / Revenue 5.43% 8.51%
Basic Earnings Per Share $0.33
Diluted Earnings Per Share $0.18 $0.33
COMMON SHARES
Basic Shares Outstanding 15.26M 15.25M
Diluted Shares Outstanding 15.25M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $168.1M $162.1M
YoY Change 648.77% 796.33%
Cash & Equivalents $37.83M $31.39M
Short-Term Investments $130.3M $130.7M
Other Short-Term Assets $1.695M $4.084M
YoY Change -3.58% 288.95%
Inventory $98.06M $105.0M
Prepaid Expenses
Receivables $28.39M $31.94M
Other Receivables $0.00 $0.00
Total Short-Term Assets $296.3M $303.1M
YoY Change 85.02% 152.47%
LONG-TERM ASSETS
Property, Plant & Equipment $21.53M $21.32M
YoY Change -31.63% 122.83%
Goodwill $6.528M
YoY Change 1.97%
Intangibles $6.092M $6.344M
YoY Change -4.45% 35.24%
Long-Term Investments $6.343M $6.556M
YoY Change -72.12% -73.77%
Other Assets $1.872M $1.489M
YoY Change -6.17% 169.26%
Total Long-Term Assets $59.26M $58.06M
YoY Change -14.12% 0.32%
TOTAL ASSETS
Total Short-Term Assets $296.3M $303.1M
Total Long-Term Assets $59.26M $58.06M
Total Assets $355.5M $361.2M
YoY Change 55.16% 102.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.891M $11.64M
YoY Change -63.14% -28.33%
Accrued Expenses $2.404M $3.335M
YoY Change -89.63% 20.92%
Deferred Revenue
YoY Change
Short-Term Debt $6.289M $10.90M
YoY Change
Long-Term Debt Due $2.112M
YoY Change
Total Short-Term Liabilities $29.00M $36.91M
YoY Change -43.89% 20.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $10.63M $11.57M
YoY Change 2.08% 10.42%
Total Long-Term Liabilities $10.63M $11.57M
YoY Change -63.45% 10.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.00M $36.91M
Total Long-Term Liabilities $10.63M $11.57M
Total Liabilities $40.35M $49.27M
YoY Change -50.51% 19.66%
SHAREHOLDERS EQUITY
Retained Earnings $127.3M $124.6M
YoY Change 34.32% 60.18%
Common Stock $153.0K $153.0K
YoY Change 10.87% 10.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $315.2M $311.9M
YoY Change
Total Liabilities & Shareholders Equity $355.5M $361.2M
YoY Change 55.16% 102.98%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $2.696M $5.218M
YoY Change -84.13% -59.06%
Depreciation, Depletion And Amortization $1.644M $1.579M
YoY Change 32.69% 94.46%
Cash From Operating Activities $6.530M $3.340M
YoY Change -36.54% 67.59%
INVESTING ACTIVITIES
Capital Expenditures $1.854M $1.729M
YoY Change -177.77% -189.96%
Acquisitions
YoY Change
Other Investing Activities $1.987M -$107.5M
YoY Change -112.28%
Cash From Investing Activities $133.0K -$109.2M
YoY Change -100.72% 5581.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -264.0K 291.0K
YoY Change -102.45% 46.97%
NET CHANGE
Cash From Operating Activities 6.530M 3.340M
Cash From Investing Activities 133.0K -109.2M
Cash From Financing Activities -264.0K 291.0K
Net Change In Cash 6.399M -105.6M
YoY Change 157.71% -39343.12%
FREE CASH FLOW
Cash From Operating Activities $6.530M $3.340M
Capital Expenditures $1.854M $1.729M
Free Cash Flow $4.676M $1.611M
YoY Change -63.11% -58.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7319000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13619000 usd
CY2023Q2 clfd Factoring Liabilities
FactoringLiabilities
8722000 usd
CY2022Q3 clfd Factoring Liabilities
FactoringLiabilities
4391000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
36913000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
51694000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
0 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
18666000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
311934000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
123429000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
638000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
12745000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15254341
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13772269
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16650000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000796505
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q2 clfd Financing Receivable Limit
FinancingReceivableLimit
12500000 eur
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
clfd Debt Securities Available For Sale Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleOtherThanTemporaryImpairment
0 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31385000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16650000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
130726000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
5802000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31944000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53704000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
105003000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
82208000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4084000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1758000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
303142000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
160122000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21318000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18229000 usd
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
6556000 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
22747000 usd
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
6581000 usd
CY2022Q3 us-gaap Goodwill Gross
GoodwillGross
6402000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6344000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6376000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14773000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13256000 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
998000 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1414000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1489000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
582000 usd
CY2023Q2 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
36741000 usd
CY2022Q3 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
50777000 usd
CY2023Q2 us-gaap Assets
Assets
361201000 usd
CY2022Q3 us-gaap Assets
Assets
229128000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3722000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3385000 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
2174000 usd
CY2022Q3 us-gaap Debt Current
DebtCurrent
0 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11641000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
24118000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3335000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6181000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
19074000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
29307000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13449000 usd
CY2022Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
-0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7060000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16629000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1842000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3884000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5218000 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13899698
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5218000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
12745000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
15000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-235000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-49000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-34000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-235000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5184000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12510000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
305399000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1059000 usd
CY2023Q2 clfd Stock Issued During Period Value Withholding Related To Stock Options Exercised
StockIssuedDuringPeriodValueWithholdingRelatedToStockOptionsExercised
-20000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
312000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-34000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5218000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
294000 usd
CY2022Q2 clfd Stock Issued During Period Value Withholding Related To Stock Options Exercised
StockIssuedDuringPeriodValueWithholdingRelatedToStockOptionsExercised
-97000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-235000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
12745000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
136774000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
147582000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2504000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
954000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
612000 usd
clfd Stock Issued During Period Value Withholding Related To Stock Options Exercised
StockIssuedDuringPeriodValueWithholdingRelatedToStockOptionsExercised
-493000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
954000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
130262000 usd
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
1630000 usd
us-gaap Net Income Loss
NetIncomeLoss
29837000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
311934000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
103825000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1647000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
544000 usd
clfd Stock Issued During Period Value Withholding Related To Stock Options Exercised
StockIssuedDuringPeriodValueWithholdingRelatedToStockOptionsExercised
379000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
274000 usd
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-960000 usd
us-gaap Net Income Loss
NetIncomeLoss
32370000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
136774000 usd
us-gaap Net Income Loss
NetIncomeLoss
29837000 usd
us-gaap Net Income Loss
NetIncomeLoss
32370000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4411000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2205000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2429000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
31000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2504000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1647000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-24519000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12156000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21510000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
41816000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3525000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
185000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-20326000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8677000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13481000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9289000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6529000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6764000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
210923000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
248000 usd
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
105077000 usd
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
17386000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-112375000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10374000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
16700000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-0 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
612000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
544000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
954000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
274000 usd
clfd Payments For Proceeds From Tax Withholding Stock Options Exercised
PaymentsForProceedsFromTaxWithholdingStockOptionsExercised
493000 usd
clfd Payments For Proceeds From Tax Withholding Stock Options Exercised
PaymentsForProceedsFromTaxWithholdingStockOptionsExercised
379000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
954000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
130262000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
113681000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-109000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-52000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14735000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
976000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16650000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13216000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31385000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14194000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12589000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9913000 usd
us-gaap Interest Paid Net
InterestPaidNet
360000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
566000 usd
clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
276000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5218000 usd
us-gaap Net Income Loss
NetIncomeLoss
29837000 usd
us-gaap Net Income Loss
NetIncomeLoss
32370000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14880666
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13760950
CY2023Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
127429
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
48739
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
139069
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15254341
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13899698
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14929405
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13900019
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.35
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.33
CY2023Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
6750000 usd
CY2022Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
16635000 usd
CY2023Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
24635000 usd
CY2022Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
15000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31385000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
340000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
151000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
25124000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
982000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
50 pure
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
6345000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
176000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
22204000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1414000 usd
CY2023Q2 clfd Cash Equivalents Fair Value Disclosure
CashEquivalentsFairValueDisclosure
24635000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
137282000 usd
CY2022Q3 clfd Cash Equivalents Fair Value Disclosure
CashEquivalentsFairValueDisclosure
15000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
28549000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1059000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2504000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
638000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1647000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5385000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
40266
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
64.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
62730
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
66.48
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6314 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0375 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
236509
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
40266
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
64.38
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
21630
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
26.16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1021
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
18.18
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
254124
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.04
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y6M10D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2193000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61284000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71250000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
219035000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
175854000 usd
CY2023Q2 clfd Revenues Percent
RevenuesPercent
1 pure
CY2022Q2 clfd Revenues Percent
RevenuesPercent
1 pure
clfd Revenues Percent
RevenuesPercent
1 pure
clfd Revenues Percent
RevenuesPercent
1 pure
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
79000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
79000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
77386000 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
69142000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3501000 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
4592000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
29197000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10803000 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
110084000 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
84537000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5081000 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2329000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
105003000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
82208000 usd
CY2023Q2 clfd Number Of Patents Granted
NumberOfPatentsGranted
47 pure
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61284000 usd
CY2023Q2 us-gaap Revenue Not From Contract With Customer Excluding Interest Income
RevenueNotFromContractWithCustomerExcludingInterestIncome
0 usd
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
1630000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
195000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1579000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1059000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1842000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5218000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1729000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
219035000 usd
us-gaap Revenue Not From Contract With Customer Excluding Interest Income
RevenueNotFromContractWithCustomerExcludingInterestIncome
0 usd
us-gaap Net Investment Income
NetInvestmentIncome
3328000 usd
us-gaap Interest Expense
InterestExpense
551000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4411000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2504000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8511000 usd
us-gaap Net Income Loss
NetIncomeLoss
29837000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6531000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
6581000 usd
CY2023Q1 us-gaap Assets
Assets
361201000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
6402000 usd
CY2022Q3 us-gaap Assets
Assets
229128000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3433000 usd
CY2023Q2 clfd Factoring Liabilities
FactoringLiabilities
8722000 usd
CY2023Q2 clfd Financing Receivables Percentage Of Cash Initially Received
FinancingReceivablesPercentageOfCashInitiallyReceived
0.80 pure
CY2023Q2 clfd Financing Receivable Percentage Of Balance Received When Invoice Is Paid
FinancingReceivablePercentageOfBalanceReceivedWhenInvoiceIsPaid
0.20 pure
CY2023Q2 clfd Financing Receivable Limit
FinancingReceivableLimit
13600000 usd
CY2023Q2 clfd Financing Receivable Average Interest Rate During Period
FinancingReceivableAverageInterestRateDuringPeriod
0.0429 pure
clfd Financing Receivable Average Interest Rate During Period
FinancingReceivableAverageInterestRateDuringPeriod
3.49 pure
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1842000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8511000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.222 pure
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3884000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9480000 usd
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.227 pure
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1092000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
851000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
3173000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
1687000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1302000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4217000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3253000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1583000 usd
CY2023Q2 clfd Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
3097000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
16885000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1591000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
15294000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0358 pure
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y5M19D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0305 pure
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1012000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2910000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
617000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1167000 usd

Files In Submission

Name View Source Status
0001171843-23-005112-index-headers.html Edgar Link pending
0001171843-23-005112-index.html Edgar Link pending
0001171843-23-005112.txt Edgar Link pending
0001171843-23-005112-xbrl.zip Edgar Link pending
clfd-20230630.xsd Edgar Link pending
clfd20230630_10q.htm Edgar Link pending
ex_550131.htm Edgar Link pending
ex_550132.htm Edgar Link pending
ex_550133.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
clfd-20230630_def.xml Edgar Link unprocessable
clfd-20230630_lab.xml Edgar Link unprocessable
clfd-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clfd20230630_10q_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clfd-20230630_cal.xml Edgar Link unprocessable